Bruce C. Cozadd, Director at Jazz Pharmaceuticals plc (JAZZ), sold 7,219 shares at $250.13 ($1.8M) on 2026-09-01, disclosed to the SEC on 2026-09-02.
Scheduled sale ($1.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $241.39 | 1,209 | $292K | 16.3% |
| 2 | $244.06 | 10 | $2K | 0.1% |
| 3 | $250.13 | 6,000 | $1.5M | 83.6% |
| Total | $248.66 avg | 7,219 | $1.8M | 100% |
| Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |
| JAZZ | SELL | 2026-04-03 | $1.1M | — | Filing → |